HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Supplemental Data Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints/Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Jeong, J. A. Articles by Kim, H. Search for Related Content PubMed PubMed Citation Articles by Jeong, J. A. Articles by Kim, H.

STEM CELL GENETICS AND GENOMICS

Genome-Wide Differential Gene Expression Profiling of Human Bone Marrow Stromal Cells

^aBiotherapeutic Division, GenExel-Sein Inc., Daejon, Korea;
^bDepartment of Biological Sciences, KAIST, Daejon, Korea

Key Words. Bone marrow stromal cells • Genome-wide differential gene expression profile • DNA microarray

Correspondence: Hoeon Kim, Ph.D., Biotherapeutic Division, GenExel-Sein Inc., 373-1 Kusong-dong, Yusong-gu, Daejon, 305-701, Korea. Telephone: 82-42-862-2503; Fax: 82-2-862-2504; e-mail: hoeonkim{at}genexel.com

Received September 26, 2006; accepted for publication November 30, 2006.


Bone marrow stromal cells (BMSCs) reside in bone marrow and provide a lifelong source of new cells for various connective tissues. Although human BMSCs are regarded as highly suitable for the development of cell therapeutics and regenerative medicine, the molecular factors and the networks of signaling pathways responsible for their biological properties are as yet unclear. To gain a comprehensive understanding of human BMSCs at the transcriptional level, we have performed DNA microarray-based, genome-wide differential gene expression analysis with the use of peripheral blood-derived mononuclear cells (MNCs) as a baseline. The resulting molecular profile of BMSCs was revealed to share no meaningful overlap with those of other human stem cell types, suggesting that the cells might express a unique set of genes for their stemness. By contrast, the distinct molecular signature, consisting of 92 different genes whose expression strengths are at least 50-fold higher in BMSCs compared with MNCs, was shown to encompass largely a gene subset of umbilical cord blood-derived adherent cells, suggesting that adherent cells derived from bone marrow and umbilical cord blood may be defined by a common set of genes, regardless of their origin. Intriguingly, a large number of these genes, particularly ones for extracellular matrix products, coincide with normal or tumor endothelium-specific markers. Taken together, our results here provide a BMSC-specific genetic catalog that may facilitate future studies on molecular mechanisms governing core properties of these cells.

Disclosure of potential conflicts of interest is found at the end of this article.